Company News in the Life Science Industry

»

Reset 

ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company

LOS ANGELES, July 16, 2019 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (OTC: IMUC), today announced an agreement with a privately held biotechnology company (the "Purchaser") for the purchase of substantially all of ImmunoCellular's remaining clinical and pre-clinical... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019
Related companies:  ImmunoCellular Therapeutics, Ltd.

Protagonist Therapeutics Reports Granting of Inducement Award

NEWARK, Calif., July 16, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on July 15, 2019, it issued an inducement award to Sarita Khanna, Ph.D., the Company's recently hired Vice President of Biostatistics, in accordance with the terms of Dr. Khanna's employment... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019
Related companies:  Protagonist Therapeutics Inc.

GLOBAL DISPOSABLE MEDICAL DEVICES MARKET FORECAST 2019-2027

NEW YORK, July 16, 2019 /PRNewswire/ -- KEY FINDINGS
Disposable medical gloves are known to offer protection against various complicated activities that involve handling toxic chemicals, reactive materials, or scenarios involving unhygienic conditions.



Read the... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

Global Endovenous Ablation Devices Market 2019-2023

NEW YORK, July 16, 2019 /PRNewswire/ -- Global Endovenous Ablation Devices Market: About this market

Endovenous ablation devices are used to treat chronic venous insufficiency (CVI) with varicose veins. These devices are designed to perform minimally invasive procedures. This... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer

SAN JOSE, Calif., July 16, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announces the appointment of Steven M. Bosacki, a 20 year pharmaceutical industry veteran, as its... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019
Related companies:  BioPharmX, Inc.

Tradipitant Effective in Preventing Motion Sickness

WASHINGTON, July 16, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that tradipitant, a neurokinin-1 receptor antagonist, was effective in treating motion sickness in a clinical study conducted in the Pacific Ocean.

Read more ››
By: PR Newswire Association LLC. - 16 Jul 2019
Related companies:  Vanda Pharmaceuticals Inc.

Aratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health

LEAWOOD, Kan., July 16, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the three proposals considered and voted upon... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019
Related companies:  Aratana Therapeutics, Inc.

Germany Diabetes Market to 2024: Epidemiology, Trends, Therapeutic Structure, Competitive Structure, Outlook

DUBLIN, July 16, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

GLOBAL OSSEOINTEGRATION IMPLANTS MARKET FORECAST 2019-2027

NEW YORK, July 16, 2019 /PRNewswire/ -- KEY FINDINGS
Osseointegration procedure entails the first interlocking between the alveolar bone and implant body, following which the biological fixation happens through the continuous bone apposition and remodeling of the implant. The global... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

Altaire Pharmaceuticals, Inc. Issues Voluntary Recall Of Over-The-Counter Ophthalmic Products Sold By Natural Ophthalmics And TRP Company, Inc.

AQUEBOGUE, N.Y., July 16, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Over-the-Counter (OTC) drug products and lots, within expiry, sold by Natural Ophthalmics and TRP Company, Inc. during the time period as indicated in the tables... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

Pennsylvania legislation signed into law by Governor Wolf providing rural trauma center funding and optimizing trauma center placement

HARRISBURG, Pa., July 16, 2019 /PRNewswire/ -- On July 2(nd) Governor Tom Wolf signed HB 786 into law. HB 786 was the culmination of discussions that started more than ten years ago by the Board of Directors of the Pennsylvania Trauma Systems Foundation (PTSF) on how to assure injured patients... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

Penumbra, Inc. Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019

ALAMEDA, Calif., July 16, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2019 after market close on Tuesday, August 6, 2019 at 4:30 PM Eastern Time. A press release with second quarter 2019... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019
Related companies:  Penumbra, Inc.

The Leukemia & Lymphoma Society's Silicon Valley & Monterey Bay Area Chapter Announces Local 2019 Man & Woman of the Year Winners

MONTEREY BAY AREA, Calif., July 16, 2019 /PRNewswire/ -- A Carmel woman and a Monterey man have been named the winners of this year's Man & Woman of the Year Campaign presented by Scheid Family Wines and Salinas Valley Memorial Healthcare System. The campaign is a part of The Leukemia &... Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

Ublituximab Drug Overview 2019: An Anti-CD20 Monoclonal Antibody, Currently in Late-Stage Trials Across a Range of Hematological and Neurological Indications

DUBLIN, July 16, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

The global coronary stent market is likely to reach more than $11 billion by 2024

NEW YORK, July 16, 2019 /PRNewswire/ --

The global coronary stent market is likely to reach more than $11 billion by 2024, growing at a CAGR of around 7% during 2018-2024.



Read the full report: Read more ››

By: PR Newswire Association LLC. - 16 Jul 2019

CorVel Announces Quarterly Earnings Release Webcast

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jul 2019

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2019

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jul 2019
Related companies:  Genmab A/S

Kane Biotech Announces New Agreement with FreeMind Group

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jul 2019
Related companies:  Kane Biotech Inc.

Atara Biotherapeutics Announces Plan to Initiate Tab-cel® FDA Biologics License Application Submission Next Year

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jul 2019
Related companies:  Atara Biotherapeutics, Inc.

YSS Corp. Announces Receipt of Eleventh Retail Cannabis Store License

Read more ››
By: Nasdaq / GlobenewsWire - 16 Jul 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies